Rattray M, Lautar S L, Uhl G R
Gene Neuroscience Unit, Addiction Research Center/NIDA, Baltimore, MD.
Brain Res Mol Brain Res. 1990 Apr;7(3):249-59. doi: 10.1016/0169-328x(90)90035-c.
In this paper we validate a methodology, ligand autoradiographic receptor screening (LARS), for detecting expression of full length receptor cDNAs in COS cells. The method involves transfection of COS cells with receptor cDNAs by spheroplast fusion, production of filter replicas of the cell fragments, ligand binding to the receptors expressed in the membranes, and autoradiographic detection of bound ligand. A beta-adrenergic receptor cDNA cloned into a eukaryotic expression vector reliably induces high levels of beta-adrenergic receptor expression in 2-12% of COS cell colonies transfected with this plasmid after experimental conditions are optimized. Receptor expression is monitored by autoradiographic detection of 125iodocyanopindolol binding to COS cell fragments immobilized on polyester filter replicas. Binding displays appropriate pharmacological properties. The number of high-density binding spots per filter depends on the fraction of the spheroplasts in the fusion mixture that contain the beta-adrenergic receptor cDNA. A 100-plate LARS experiment can assess receptor expression in more than 10(4) transfected colonies. Thus detection of receptor-encoding sequences present in libraries in proportions as low as 1 in 10(4) should be possible. This technique may therefore be useful in detecting expression of other receptor cDNAs for which selective radioligands are available.
在本文中,我们验证了一种用于检测COS细胞中全长受体cDNA表达的方法——配体放射自显影受体筛选(LARS)。该方法包括通过原生质球融合将受体cDNA转染到COS细胞中,制作细胞片段的滤膜复制品,使配体与膜上表达的受体结合,以及通过放射自显影检测结合的配体。将克隆到真核表达载体中的β-肾上腺素能受体cDNA在优化实验条件后,能可靠地在2%至12%转染该质粒的COS细胞集落中诱导高水平的β-肾上腺素能受体表达。通过放射自显影检测固定在聚酯滤膜复制品上的COS细胞片段与125碘氰吲哚洛尔的结合来监测受体表达。结合表现出适当的药理学特性。每个滤膜上高密度结合位点的数量取决于融合混合物中含有β-肾上腺素能受体cDNA的原生质球的比例。一个100板的LARS实验可以评估超过10⁴个转染集落中的受体表达。因此,有可能检测到文库中比例低至1/10⁴的受体编码序列。所以,这项技术可能有助于检测其他有选择性放射性配体的受体cDNA的表达。